You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

SYNTHROID Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Synthroid, and when can generic versions of Synthroid launch?

Synthroid is a drug marketed by Abbvie and is included in one NDA.

The generic ingredient in SYNTHROID is levothyroxine sodium. There are ten drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the levothyroxine sodium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Synthroid

A generic version of SYNTHROID was approved as levothyroxine sodium by MYLAN on June 5th, 2002.

  Try a Trial

Drug patent expirations by year for SYNTHROID
Drug Prices for SYNTHROID

See drug prices for SYNTHROID

Drug Sales Revenue Trends for SYNTHROID

See drug sales revenues for SYNTHROID

Recent Clinical Trials for SYNTHROID

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
VA Office of Research and DevelopmentPhase 2
VA Office of Research and DevelopmentPhase 4
Central Arkansas Veterans Healthcare SystemPhase 4

See all SYNTHROID clinical trials

Pharmacology for SYNTHROID
Drug Classl-Thyroxine

US Patents and Regulatory Information for SYNTHROID

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie SYNTHROID levothyroxine sodium TABLET;ORAL 021402-001 Jul 24, 2002 AB1,AB2 RX Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Abbvie SYNTHROID levothyroxine sodium TABLET;ORAL 021402-007 Jul 24, 2002 AB1,AB2 RX Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Abbvie SYNTHROID levothyroxine sodium TABLET;ORAL 021402-004 Jul 24, 2002 AB1,AB2 RX Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Abbvie SYNTHROID levothyroxine sodium TABLET;ORAL 021402-011 Jul 24, 2002 AB1,AB2 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.